Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.85 USD | +16.35% | +12.80% | -22.59% |
Mar. 13 | HC Wainwright Cuts Rallybio Price Target to $9 From $12, Maintains Buy Rating | MT |
Mar. 12 | Rallybio Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.59% | 60.12M | |
+9.30% | 45.97B | |
+52.73% | 43.93B | |
+7.15% | 42.34B | |
-8.78% | 28.27B | |
+18.68% | 27.18B | |
-21.92% | 19.44B | |
+14.62% | 13.83B | |
+31.85% | 12.4B | |
+4.47% | 11.45B |
- Stock
- Equities
- Stock Rallybio Corporation - Nasdaq
- News Rallybio Corporation
- Rallybio Secures Global Rights to Sanofi's Antibody Candidate to Treat Anemia